Plug and play is actually a computer terminology. It refers to components you can easily plug in and it works without you having to do any configuration or install any software. For example a USB mouse, plug it in and it works.
It sounds like they want Rexista to be something you can license and sell without having to worry about development or FDA approval and such.
This is why I suggested we might not see a deal until near approval. It looks like IPCI is preparing for the march conference to try and impress someone to partner up.
Could Rexista be the alternative for Teva? Or other players wants it, we can only speculate right now.
News 
Market Data 
Discover 
AI
